gefitinib has been researched along with 4-(3-chloroanilino)quinazoline in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (4-(3-chloroanilino)quinazoline) | Trials (4-(3-chloroanilino)quinazoline) | Recent Studies (post-2010) (4-(3-chloroanilino)quinazoline) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 8 | 0 | 2 |
| Protein | Taxonomy | gefitinib (IC50) | 4-(3-chloroanilino)quinazoline (IC50) |
|---|---|---|---|
| Acyl-CoA (8-3)-desaturase | Homo sapiens (human) | 0.011 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 0.5402 | |
| Beta-2 adrenergic receptor | Rattus norvegicus (Norway rat) | 0.011 | |
| Beta-1 adrenergic receptor | Rattus norvegicus (Norway rat) | 0.011 | |
| Beta-3 adrenergic receptor | Rattus norvegicus (Norway rat) | 0.011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, J; Song, Z; Tang, Z; Wang, L; Wang, Z; Wu, X; Zhang, J | 1 |
1 other study(ies) available for gefitinib and 4-(3-chloroanilino)quinazoline
| Article | Year |
|---|---|
Facile and efficient synthesis and biological evaluation of 4-anilinoquinazoline derivatives as EGFR inhibitors.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; ErbB Receptors; Humans; Molecular Structure; Protein Kinase Inhibitors; Quinazolines; Structure-Activity Relationship | 2016 |